These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20608290)

  • 21. Chemistry strategies in early drug discovery: an overview of recent trends.
    Colombo M; Peretto I
    Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence-based protein kinase inhibition: applications for drug development.
    Wexler I; Niv M; Reuveni H
    Biotechniques; 2005 Oct; 39(10 Suppl):S575-6. PubMed ID: 18957040
    [No Abstract]   [Full Text] [Related]  

  • 23. Current challenges in pediatric drug development.
    Adamson PC
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):883-4. PubMed ID: 19209138
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson's disease.
    Shah U; Hodgson R
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):466-80. PubMed ID: 20597030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Picking up the pieces with FBDD or FADD: invest early for future success.
    Whittaker M
    Drug Discov Today; 2009 Jul; 14(13-14):623-4. PubMed ID: 19486947
    [No Abstract]   [Full Text] [Related]  

  • 26. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of open chemical data in aiding drug discovery and design.
    Gaulton A; Overington JP
    Future Med Chem; 2010 Jun; 2(6):903-7. PubMed ID: 21426107
    [No Abstract]   [Full Text] [Related]  

  • 28. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 29. Computational mapping tools for drug discovery.
    Ivanenkov YA; Savchuk NP; Ekins S; Balakin KV
    Drug Discov Today; 2009 Aug; 14(15-16):767-75. PubMed ID: 19520185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular pharmacology in the post-blockbuster era.
    Brandes RP
    Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA's critical path initiative: a brief introduction.
    Coons SJ
    Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug discovery dilemma and Cura quartet collaboration.
    Shah S; Federoff HJ
    Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 36. The promise of imaging biomarkers.
    Drug News Perspect; 2010 Mar; 23(2):119-23. PubMed ID: 20369077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitors try collaboration to speed drug development.
    Patlak M
    J Natl Cancer Inst; 2010 Jun; 102(12):841-3. PubMed ID: 20530762
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV vaccine development: Lessons from the past, informing the future.
    Bradac J; Dieffenbach CW
    IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The need for precompetitive integrative bionetwork disease model building.
    Friend SH
    Clin Pharmacol Ther; 2010 May; 87(5):536-9. PubMed ID: 20407459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.